Want to see AU:CBL full AI Analyst Report?
Control Bionics Ltd. (CBL) Stock Statistics & Valuation Metrics
Total Valuation
Control Bionics Ltd. has a market cap or net worth of AUD 28.29M. The enterprise value is AUD 29.03M.
- Market Cap
- AUD 28.29M
- Enterprise Value
- AUD 29.03M
Share Statistics
Control Bionics Ltd. has 544,132,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 544,132,800
- Owned by Insiders
- 3.42%
- Owned by Institutions
- ―
Financial Efficiency
Control Bionics Ltd.’s return on equity (ROE) is -1.15 and return on invested capital (ROIC) is -98.72%.
- Return on Equity (ROE)
- -1.15
- Return on Assets (ROA)
- -0.80
- Return on Invested Capital (ROIC)
- -98.72%
- Return on Capital Employed (ROCE)
- -1.15
- Revenue Per Employee
- 190.67K
- Profits Per Employee
- -290.62K
- Employee Count
- 25
- Asset Turnover
- 0.53
- Inventory Turnover
- 19.72
Valuation Ratios
The current PE Ratio of Control Bionics Ltd. is -2.63. Control Bionics Ltd.’s PEG ratio is -0.15.
- PE Ratio
- -2.63
- PS Ratio
- 5.94
- PB Ratio
- 3.39
- Price to FCF
- -4.91
- Price to Operating Cash Flow
- -3.73
- PEG Ratio
- -0.15
Income Statement
In the last 12 months, Control Bionics Ltd. had revenue of 4.77M and earned -7.27M in profits. Earnings per share was -0.02.
- Revenue
- 4.77M
- Gross Profit
- -4.14M
- Operating Income
- -7.29M
- Pretax Income
- -7.72M
- Net Income
- -7.27M
- EBITDA
- -7.29M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -5.75M and capital expenditures -10,033, giving a free cash flow of -5.76M billion.
- Operating Cash Flow
- -5.75M
- Free Cash Flow
- -5.76M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Control Bionics Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -20.35%
- Earnings Yield
- -33.92%
Stock Price Statistics
- Beta
- -0.09
- 52-Week Price Change
- 52.94%
- 50-Day Moving Average
- 0.06
- 200-Day Moving Average
- 0.06
- Relative Strength Index (RSI)
- 37.48
- Average Volume (3m)
- 582.13K
Important Dates
Control Bionics Ltd. upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Control Bionics Ltd. as a current ratio of 1.54, with Debt / Equity ratio of 9.80%
- Current Ratio
- 1.54
- Quick Ratio
- 1.37
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 0.20
- Interest Coverage Ratio
- -85.78
Taxes
In the past 12 months, Control Bionics Ltd. has paid -454.20K in taxes.
- Income Tax
- -454.20K
- Effective Tax Rate
- 0.06
Enterprise Valuation
Control Bionics Ltd. EV to EBITDA ratio is -3.91, with an EV/FCF ratio of -4.66.
- EV to Sales
- 5.63
- EV to EBITDA
- -3.91
- EV to Free Cash Flow
- -4.66
- EV to Operating Cash Flow
- -4.67
Balance Sheet
Control Bionics Ltd. has AUD 2.08M in cash and marketable securities with AUD 618.92K in debt, giving a net cash position of AUD 1.46M billion.
- Cash & Marketable Securities
- AUD 2.08M
- Total Debt
- AUD 618.92K
- Net Cash
- AUD 1.46M
- Net Cash Per Share
- AUD 0.00
- Tangible Book Value Per Share
- AUD 0.00
Margins
Gross margin is -82.20%, with operating margin of -152.96%, and net profit margin of -152.42%.
- Gross Margin
- -82.20%
- Operating Margin
- -152.96%
- Pretax Margin
- -161.95%
- Net Profit Margin
- -152.42%
- EBITDA Margin
- -144.00%
- EBIT Margin
- -152.96%
Analyst Forecast
The average price target for Control Bionics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -22.43%
- EPS Growth Forecast
- 15.02%
Scores
- Smart Score
- 9
- AI Score
- 42